ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,982.54
-0.03%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.425
0.19%
Brent Oil
82.275
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Aprea Therapeutics Inc (APRE)

  7. Aprea Therapeutics Inc (APRE) ニュース

APRE

Aprea Therapeutics (APRE)

Aprea Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:APRE
日付受信時刻ニュースソース見出しコード企業名
2024/05/1421 : 40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2024/05/1421 : 35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
2024/02/0707 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2024/02/0514 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APREAprea Therapeutics Inc
2024/02/0306 : 26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2024/01/2621 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2024/01/2620 : 03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:APREAprea Therapeutics Inc
2024/01/0506 : 16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/11/1006 : 20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APREAprea Therapeutics Inc
2023/11/1006 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/11/1006 : 10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
2023/10/1706 : 29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/10/1320 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/09/1121 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/08/2510 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
2023/08/2510 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
2023/08/2510 : 48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APREAprea Therapeutics Inc
2023/08/2421 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/08/1020 : 39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APREAprea Therapeutics Inc
2023/08/1020 : 36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/07/1120 : 40Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:APREAprea Therapeutics Inc
2023/07/1120 : 30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APREAprea Therapeutics Inc
2023/07/0605 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APREAprea Therapeutics Inc
2023/06/1421 : 00GlobeNewswire Inc.Aprea Therapeutics to Present at Maxim Virtual Healthcare ConferenceNASDAQ:APREAprea Therapeutics Inc
2023/06/0905 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APREAprea Therapeutics Inc
2023/05/3021 : 30GlobeNewswire Inc.Aprea Therapeutics to Present at BIO International ConventionNASDAQ:APREAprea Therapeutics Inc
2023/05/1605 : 48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APREAprea Therapeutics Inc
2023/05/1605 : 40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APREAprea Therapeutics Inc
2023/05/1605 : 05GlobeNewswire Inc.Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business OperationsNASDAQ:APREAprea Therapeutics Inc
2023/05/0906 : 16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APREAprea Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:APRE

最近閲覧した銘柄

NASDAQ
AMZN
Amazon.com
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
CCOM
US30
US 30
NASDAQ
MSFT
Microsoft
USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
CCOM
US500
US 500
USI
USTECH100
US Tech 100
AMEX
SPY
SPDR S&P 500
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
XOM
Exxon Mobil
NYSE
VZ
Verizon Communications
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有